Research and products:
Biological Drug candidate HAS2021 is based on Primecell´s fifteen years experience with cell and tissue products and extraordinary orthopedics outputs of University hospital in Prague.
Cytokine Bioscience is a spin-off of Primecell´s research labs 4MEDi and NATIC, similarly as a spin-off Biohealing (2018).
Research of HAS2021 was granted by the Technology Agency of the Czech Republic, ID Trend1/FW01010339 in 2019.
Project INNOBOOSTER: Global Business Development Officer is co-financed by the Moravian-Silesian Region within the framework of the grant program Support for Entrepreneurship in the Moravian-Silesian Region 2022.
Prof. Martin Krbec, MD, Ph.D.
Head of orthopedic clinic University hospital, Vice-chairman of Orthopedic society
Prof. Valer Dzupa, MD
Vice dean School of medicine,
Charles University Prague
MSc. Iveta Schmiedova
Head of the project, Statutary representative of Cytokine
MSc. Lucia Pistorova
MSc. Zuzana Maceckova, Ph.D.
Head of Research
MSc. Michal Zahradnicek, MBA
Biomed enterpreneur venture,
4MEDI biotech accelerator